Horizon Capital makes third deal from HCGF IV with Viseven

Viseven is a global marketing tech provider to the pharma and life sciences industry.

  • Viseven is based in Tallinn, Estonia
  • Horizon is a private equity firm in emerging Europe with over $1.5bn in assets
  • The firm is based in Kyiv

Horizon Capital has invested in Viseven, a global marketing tech provider servicing the pharma and life sciences industry.

Tallinn, Estonia-based Viseven has expanded to over 30 countries, with development hubs in Ukraine, as well as Argentina, Estonia, India, Poland and North America. It has grown at a consistent rate, more than tripling revenues since 2019.

The company has AVentures Capital and Horizon Capital among its investors and remains founders’ led.

This transaction is the third investment from Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.

“I am delighted to announce Horizon Capital’s investment in another global tech champion out of Ukraine, in a sign of enduring resilience for our region,” said Lenna Koszarny, founding partner and CEO at Horizon Capital. “As a 2X Flagship Fund, promoting gender-smart investing, we are particularly proud to be backing a woman-founded and led technology company, making this investment even more meaningful.”

Kyiv-based Horizon Capital is a private equity firm in emerging Europe with over $1.5 billion in assets. It invests primarily in tech and export-oriented businesses in Ukraine and Moldova.

No financial details of the transaction were disclosed.